Trial intelligence / Profile preview

Clozapine vs Olanzapine for Comorbid Psychosis and Substance Use

NCT03857581Phase 4Unknown

Sponsor
Augusta University
Start
Jul 2020
Primary completion
Jul 2021
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 4, randomised trial of clozapine in psychotic disorder and substance use disorder (SUD) (2 arms), sponsored by Augusta University. Primary endpoint: Frequencies of positive urine drug screens and breathalyzer alcohol levels at 12 weeks. Status: unknown.

02

Drugs

clozapine
03

Conditions

psychotic disordersubstance use disorder (SUD)

Beyond the preview

Go deeper on NCT03857581.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03857581.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call